Lebecque, B.; Bourgne, C.; Munje, C.; Berger, J.; Tassin, T.; Cony-Makhoul, P.; Guerci-Bresler, A.; Johnson-Ansah, H.; Liu, W.; Saugues, S.;
et al. The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia. Cancers 2022, 14, 4695.
https://doi.org/10.3390/cancers14194695
AMA Style
Lebecque B, Bourgne C, Munje C, Berger J, Tassin T, Cony-Makhoul P, Guerci-Bresler A, Johnson-Ansah H, Liu W, Saugues S,
et al. The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia. Cancers. 2022; 14(19):4695.
https://doi.org/10.3390/cancers14194695
Chicago/Turabian Style
Lebecque, Benjamin, Celine Bourgne, Chinmay Munje, Juliette Berger, Thomas Tassin, Pascale Cony-Makhoul, Agnès Guerci-Bresler, Hyacinthe Johnson-Ansah, Wei Liu, Sandrine Saugues,
and et al. 2022. "The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia" Cancers 14, no. 19: 4695.
https://doi.org/10.3390/cancers14194695
APA Style
Lebecque, B., Bourgne, C., Munje, C., Berger, J., Tassin, T., Cony-Makhoul, P., Guerci-Bresler, A., Johnson-Ansah, H., Liu, W., Saugues, S., Tchirkov, A., Vetrie, D., Copland, M., & Berger, M. G.
(2022). The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia. Cancers, 14(19), 4695.
https://doi.org/10.3390/cancers14194695